Ultragenyx $122 million IPO explodes, doubling price in first few hours of trading

Rare disease drug developer Ultragenyx Pharmaceutical Inc. exploded onto the market Friday, setting its IPO price at $21 but climbing to just short of $48 per share by mid-day trading...